The melanocortin pathway, one of the direct
|
|
- Annis Potter
- 5 years ago
- Views:
Transcription
1 Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice Susann Blüher, 1 Mary Ziotopoulou, 1 John W. Bullen, Jr., 1 Stergios J. Moschos, 1 Linda Ungsunan, 1 Efi Kokkotou, 2 Eleftheria Maratos-Flier, 2 and Christos S. Mantzoros 1 To elucidate mechanisms of melanocortin action, we investigated the effects of a melanocortin receptor agonist (melanotetan II [MTII]) in lean C57BL/6J and obese (DIO, ob/ob, UCP1-DTA) mice. MTII administration (100 g q.i.d. i.p.) for 24 h results in similar weight loss but a more pronounced decrease of food intake in DIO mice. After 4 and 8 days of MTII treatment, however, the reduction in both food intake and body weight is more pronounced in DIO mice than in lean mice. MTII administration for 24 h prevents food deprivation induced alterations in hypothalamic neuropeptide Y (NPY) and liver adiponectin receptor 1 and adiponectin receptor 2 mrna expression, but does not alter hypothalamic mrna expression of melanocortin 4 receptor or adiponectin serum and mrna expression levels. NPY and agouti gene related protein (AgRP) mrna expression after 8 days of MTII is increased to levels comparable to pair-fed mice. In summary, 1) MTII is an effective treatment for obesity and related metabolic defects in leptin-resistant (DIO, UCP1-DTA) and leptinsensitive (ob/ob) mouse models of obesity; 2) the effects of MTII on food intake and body weight are more pronounced in DIO mice than in lean mice; 3) the tachyphylactic effect after prolonged MTII administration appears to be, at least in part, caused by a compensatory upregulation of NPY and AgRP mrna levels, whereas decreasing leptin levels may play a very minor role in mediating tachyphylaxis; and 4) alterations in adiponectin receptor mrna expression after fasting or MTII treatment may contribute to altered insulin sensitivity and needs to be studied further. Diabetes 53: 82 90, 2004 From the 1 Department of Medicine, Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and the 2 Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts. Address correspondence and reprint requests to C.S. Mantzoros, MD, Division of Endocrinology, RN 325, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Ave., Boston, MA cmantzor@caregroup.harvard.edu. Received for publication 11 December 2002 and accepted in revised form 14 October S.B. and M.Z. contributed equally to this work. AdipoR, adiponectin receptor; AgRP, agouti gene related protein; MC4R, melanocortin 4 receptor; MCH, melanocyte concentrating hormone; MTII, melanotetan II; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; WAT, white adipose tissue by the American Diabetes Association. The melanocortin pathway, one of the direct targets of leptin action in the brain (1), plays an important role in energy homeostasis. Mice with targeted deletion of the pro-opiomelanocortin (POMC) gene (2) or the melanocortin 4 receptor (MC4R) gene develop obesity associated primarily with hyperphagia and hyperinsulinemia (3). In addition, MC3 receptor knockout mice have increased fat mass and reduced lean body mass, but normal food intake, suggesting defects in energy partitioning (4). Peripheral or central administration of the synthetic nonspecific melanocortin receptor agonist melanotetan II (MTII) to fasted or neuropeptide Y (NPY)-treated mice as well as obesity-prone or genetically obese animals, such as Sprague-Dawley rats or rhesus macaques, acutely and chronically suppresses food intake and increases sympathetic nervous system activity (5 9), whereas melanocortin antagonism has opposite effects (10 13). We recently reported that MTII treatment decreases body weight, primarily by suppressing food intake and secondarily by increasing energy expenditure, and improves insulin resistance in mice (14). However, the mechanisms underlying improvement of weight loss and insulin resistance, as well as the development of tachyphylaxis after prolonged MTII administration, remain largely unknown. RESEARCH DESIGN AND METHODS Male C57BL/6J (3-week-old) and ob/ob (6-week-old) mice were purchased from The Jackson Laboratories (Bar Harbor, ME). Male UCP1-DTA mice (6 8 weeks old; FVB background) were obtained from a colony maintained at the Beth Israel Deaconess Medical Center. All animals were individually caged and handled, as previously described (15). Regular mouse chow (Purina Rodent Chow 5008; Ralston-Purina, St. Louis, MO) and water were available to all animals ad libitum, unless noted otherwise. For the long-term studies, a group of C57BL/6J mice received a Western diet for 12 weeks (WD1) (D12451; Research Diets, New Brunswick, NJ), and for the short-term study, C57BL/6J mice were fed either chow or a Western diet (WD2) (TD 88137; Harlan Teklad, Madison, WI) for 18 weeks before the experiments, as previously described (16,17). Short-term studies (24 h) Effects of short-term MTII administration in lean (C57BL/6J) mice (experiment A). A group of lean C57BL/6J mice (normal chow, n 8/group) were injected with MTII (100 g) four times a day (q.i.d.) intraperitoneally for 24 h. A PBS-treated (100 g q.i.d. i.p.) group, fed ad libitum, and a placebo group (100 l PBS q.i.d. i.p.), pair-fed to the MTII-treated group, were included as controls. Comparative evaluation of short-term MTII administration in lean (C57BL/6J) and obese (DIO) mice (experiment B). To investigate whether MTII has similar effects on acute weight loss and reduction in food intake in lean (chow-fed) and DIO mice (WD2 for 18 weeks), MTII (100 g q.i.d. i.p.) was injected for 24 h in both groups of mice. Control groups (PBS-treated and pair-fed to each of the MTII-treated groups) were also 82 DIABETES, VOL. 53, JANUARY 2004
2 S. BLÜHER AND ASSOCIATES TABLE 1 Effect of MTII administration on body weight and food intake Initial weight (g) Final weight (g) Weight loss (g) Cumulative food intake (g) Cumulative food intake (kcal) Short-term studies (24-h) C57BI/6J lean and obese PBS/chow MTII/chow Pair-fed to MTII/chow PBS/high-fat MTII/high-fat Pair-fed to MTII/high-fat Ob/ob PBS MTII UCP1-DTA PBS MTII # Pair-fed Long-term studies C57BI/6J 4-day lean and obese PBS/chow MTII/chow PBS/high-fat ## ## MTII/high-fat ## ## DIO-C57BI/6J 8-day MTII leptin vs. MTII treatment PBS MTII MTII leptin ** Pair-fed Data are means SE. Short-term studies: Effect of 24 h of MTII administration on body weight and cumulative food intake in lean C57BI/6J, DIO, ob/ob, and UCP1-DTA mice. Long-term studies: effects of 4 days of MTII administration in lean C57BI/6J and DIO mice as well as 8 days of either MTII or MTII plus leptin administration in DIO mice on body weight and cumulative food intake. P 0.05, P 0.01, P 0.001, P vs. the respective PBS-treated group; P 0.05, #P 0.01, **P vs. the pair-fed group; P 0.05, P 0.01, P vs. the MTII-treated group on chow; P 0.01, P vs. the PBS-treated group on chow; ##P 0.01 vs. both groups on chow. included (n 6). Each placebo and pair-fed group was maintained on the same diet with their corresponding treatment group. Effects of short-term MTII administration in leptin-deficient ob/ob mice (experiment C). To investigate whether MTII is also effective in reducing body weight and food intake in genetically obese leptin-sensitive mice, 100 g MTII was administered intraperitoneally q.i.d. for 24 h to ob/ob mice (n 4), using the protocol described above. The effects of MTII were compared with PBS-treated control ob/ob mice fed ad libitum (n 4/group). Effects of short-term MTII administration in leptin-resistant UCP1- DTA mice (experiment D). To assess whether obese leptin-resistant UCP1- DTA mice respond to short-term MTII administration in a similar fashion to DIO mice, MTII (100 g q.i.d. i.p.) was administered to UCP1-DTA mice (n 5). PBS-treated and pair-fed groups (n 5/group) were included as described above. Long-term studies Comparative evaluation of chronic MTII administration in lean (C57BL/6J) and obese (DIO) mice (4 days) (experiment E). To investigate whether lean mice (chow) respond differently to chronic MTII administration than DIO mice (WD1 for 18 weeks), MTII was injected (100 g q.i.d. i.p.) for 4 days to both groups. Two PBS-treated (100 g q.i.d. i.p.) control groups (one fed chow, the other a Western diet) were included (n 6 per group). Blood was collected by a tail bleed. Effect of MTII and MTII plus leptin administration in DIO mice (8 days) (experiment F). To investigate whether the plateauing effects of prolonged MTII administration on decreased food intake and weight loss (tachyphylaxis) is due to a decline in serum leptin, four groups of DIO mice (WD1 for 12 weeks) were studied. The first group was injected with MTII (100 g q.i.d. i.p.) for 8 days, and the second group received replacement doses of leptin (Eli Lilly, Indianapolis, IN; 1 g/g body wt b.i.d.) in addition to MTII. A PBS-treated and a pair-fed group matched to the MTII plus leptin treated group were included as controls (n 8/group). Physiological characterization. Body weight and food intake were measured daily between 8:00 and 10:00 A.M. (14). Body composition for the long-term experiment was measured by whole-carcass analysis (16,17). Animals were killed, and hypothalami were isolated. Serum, white adipose tissue (WAT), and the liver were collected and stored as previously described (17). Medication used and hormone assays. MTII was purchased from Bachem Bioscience (King of Prussia, PA) and dissolved in sterile PBS (14). Leptin was provided as a gift by Eli Lilly. Serum hormone concentrations were assessed by radioimmunoassay as previously described (17,18). RT-PCR. Hypothalamic mrna expression of NPY, agouti gene related protein (AgRP), POMC, orexin, and MC4R were assessed using semiquantitative [P 32 ]-labeled RT-PCR. NPY and POMC mrna expression in experiments B and F were confirmed using real-time PCR. Melanocyte concentrating hormone (MCH), adiponectin, and adiponectin receptor (AdipoR)-1 and AdipoR2 mrna were analyzed via real-time PCR (17 20). Statistical analysis. Descriptive characteristics of the group variables are expressed as means SE. Data for mrna expression are presented as the percent change (means SE) from the corresponding PBS group. Statistical analyses were done using the Statview program (Statview, Abacus, CA) and SPSS 8 (Texas Instruments, Chicago, IL). Statistical significance was assessed by standard Student s t tests or a two-tailed t test as well as ANOVA with post hoc corrections as appropriate. Values were considered to be significant at the P 0.05 level (two tailed). Graphs were created with GraphPadPrism (GraphPad Software, San Diego, CA). RESULTS Short-term (24-h) MTII administration results in a similar decrease in body weight in lean and obese mice but a more pronounced decrease in caloric intake in obese mice. Lean and DIO-C57BL/6J mice. We observed an average weight loss of 3.7% in both DIO and lean MTII-treated mice DIABETES, VOL. 53, JANUARY
3 MTII: TACHYPHYLAXIS IN OBESE AND LEAN MICE FIG. 1. Comparative evaluation of MTII administration for 4 days to either DIO mice fed a Western diet (WD2) or lean C57BL/6J mice fed a normal mouse chow diet (means SE). ˆP 0.09, *P < 0.05 vs. the PBS-treated group on WD2; #P < 0.05, ###P < vs. the MTIItreated group on chow; **P 0.002, ***P < vs. the respective PBS-treated group. beyond weight loss seen in the respective PBS-treated control mice after 24 h of MTII treatment (Table 1). DIO mice, however, have a more significant decrease in cumulative caloric intake (Table 1), which, if sustained for a longer period of time, would be expected to result in a more pronounced decrease in body weight. Obese leptin-sensitive ob/ob and leptin-resistant UCP1-DTA mice. Similar to lean and obese C57BL/6J mice, both ob/ob and UCP1-DTA mice exhibited a significant decrease in body weight after 24 h of MTII treatment (Table 1). MTII-treated lean C57BL/6J, obese ob/ob, and obese UCP1-DTA mice all exhibit an 38% decrease in cumulative caloric intake in comparison to PBS-treated controls, whereas MTII-treated DIO-C57BL/6J mice exhibit a % decrease in cumulative caloric intake after 24 h of MTII treatment when compared with baseline levels (P 0.001). Long-term (4-day) MTI administration results in a more pronounced reduction in food intake and body weight in DIO versus lean C57BL/6J mice. MTII treatment for 4 and 8 days decreases both caloric intake and body weight but is more effective in decreasing caloric intake and body weight in DIO versus lean C57BL/6J mice FIG. 2. Comparative evaluation of MTII administration for 4 days to either DIO mice fed a Western diet (WD2) or lean C57BL/6J mice fed normal mouse chow (means SE). Arrows indicate initiation and discontinuation of treatment. **P < 0.01, ***P < vs. the respective PBS-treated group; ##P < 0.01 vs. the MTII-treated group on chow. (Table 1, Fig. 1A and B, and Fig. 2A and B). MTII-treated DIO mice exhibited a significant decrease of 7.9% in body weight, whereas lean MTII-treated mice exhibited an 5.1% decrease in body weight beyond the respective PBS-treated control mice (Table 1, Fig. 1A, and Fig. 1B). Normalization of circulating leptin levels has only minimal effects on the tachyphylactic effect of prolonged MTII administration. We then investigated whether falling leptin levels after several days of MTII treatment are responsible for the development of tachyphylaxis (14). After 8 days, MTII-treated DIO-C57BL/6J mice exhibited a significant decrease in circulating leptin levels when compared with their PBS-treated controls ( ng/ml in the MTII-treated group vs ng/ml in the PBS-treated group, P 0.01), whereas MTII plus leptin treated DIO mice did not exhibit a significant decrease in circulating leptin levels ( ng/ml in the MTII plus leptin treated group vs ng/ml in the PBS-treated group). MTII-treated DIO mice also exhibited a significant decrease in body weight during the 8-day period ( g in the MTII-treated group vs g in the PBS-treated group, P ), but the effects of MTII appeared to plateau after 4 days of treatment (Fig. 3A and B). Once replacement doses of leptin were administered in conjunction with MTII, however, DIO mice continued to lose weight and exhibited a more significant percent decrease in body weight after 8 days of treatment 84 DIABETES, VOL. 53, JANUARY 2004
4 S. BLÜHER AND ASSOCIATES FIG. 4. Comparative evaluation of total percent body fat and triglycerides after 8 days of MTII plus leptin vs. MTII administration in DIO mice (means SE). *P < 0.05 vs. the PBS-treated group; ##P < 0.01, ###P < vs. the pair-fed < 0.05 vs. the MTII-treated group. FIG. 3. Comparative evaluation of weight loss after 8 days of MTII plus leptin versus MTII administration in DIO mice. Arrows indicate initiation and discontinuation of treatment (means SE). *P < 0.05 between the MTII- and the PBS-treated < 0.01 between the MTII plus leptin and PBS-treated groups; 0.09 > P > 0.05, #P < 0.05 between the pair-fed and PBS-treated groups; ***P < vs. the PBS-treated group; ###P vs. the pair-fed group; P between the MTII plus leptin and the MTII-treated groups. ( % in the MTII plus leptin treated group [P 0.01 vs. PBS control] vs % in the MTII-treated group [P 0.05 vs. PBS control]; Fig. 3A and B). Total percent body fat was significantly lower in MTII plus leptin treated versus MTII-treated and pair-fed DIO mice after 8 days (Fig. 4A). Total body triglycerides were significantly lower in MTII plus leptin treated versus MTIItreated, pair-fed, and PBS-treated DIO mice as well (Fig. 4B). Cumulative caloric intake was similarly reduced in both MTII- and MTII plus leptin treated groups, however ( 30% decrease for both groups, P 0.001). Effects of MTII on serum insulin and thyroxine concentrations Short-term studies (24 h). Circulating insulin levels were significantly decreased by 50% after 24 h of both MTII treatment and food deprivation in all lean and obese mice. We have previously reported that MTII treatment results in a more pronounced decrease in insulin levels compared with pair-feeding or PBS treatment (14). We observed an 64% decrease in insulin levels after 24 h of either food deprivation or MTII treatment for 24 h ( ng/ml in MTII-treated mice and in pair-fed mice vs in PBS-treated mice, 0.06 P 0.08 for both groups). Moreover, DIO mice exhibited a slightly lower ( 55.5%) decrease in insulin levels after 24 h of either food deprivation or MTII treatment ( ng/ml in the MTII-treated group and ng/ml in the pair-fed group vs ng/ml in the PBS-treated group, P 0.05 for both groups). Ob/ob mice responded to 24 h of MTII treatment similarly to lean C57BL/6J and DIO mice, with an 59.4% decrease in insulin levels ( ng/ml in the MTII-treated group vs ng/ml in the PBS-treated group, P 0.05). In UCP1-DTA mice, the effect of short-term MTII administration on circulating insulin levels was even more pronounced. Although pairfed UCP1-DTA mice had an 55% decrease in insulin levels, insulin levels were more significantly decreased by 78.8% in MTII-treated UCP1-DTA mice ( ng/ml in the MTII-treated group and ng/ml in the pair-fed group vs ng/ml in the PBS-treated group, P 0.05 for MTII-treated vs. PBS-treated mice and NS for pair-fed vs. PBS-treated mice). Long-term studies (4 8 days). The effects of MTII on insulin levels persisted after 4 days of treatment in DIO mice only (lean C57BL/6J: ng/ml in MTIItreated mice vs ng/ml in PBS-treated mice, NS; DIO: ng/ml in MTII-treated mice vs ng/ml in PBS-treated mice, P 0.001). After 8 days of treatment, serum insulin levels remained significantly decreased in DIO mice, but this difference was most pronounced in the MTII plus leptin treated group ( ng/ml in the MTII plus leptin treated group, ng/ml in the MTII-treated group, and ng/ml in the pair-fed group vs in the PBS group, P 0.05 between the MTII plus leptin and PBS-treated group only). Serum thyroxine concentrations were not significantly altered in lean, DIO, or ob/ob mice after 24 h, 4 days, or 8 DIABETES, VOL. 53, JANUARY
5 MTII: TACHYPHYLAXIS IN OBESE AND LEAN MICE FIG. 5. Hypothalamic NPY mrna expression as the percent change from the respective PBS-treated group (means SE). *P < 0.05, **P < 0.01, ***P < vs. the respective PBS-treated group; #P < 0.05, ##P < 0.01 vs. the respective MTII-treated group. days of MTII administration or pair-feeding (data not shown). Effects of short-term (24-h) MTII treatment on the mrna expression of hypothalamic neuropeptides in lean C57BL/6J, DIO, and ob/ob mice. To gain a better understanding of why tachyphylaxis occurs after prolonged MTII treatment, we investigated the expression pattern of key hypothalamic orexigenic (NPY, AgRP) and anorexigenic (POMC, orexin) neuropeptides as well as hypothalamic MC4R mrna expression. Hypothalamic NPY mrna expression increased by 40 50% after 24 h of pair-feeding induced food deprivation (P 0.01; Fig. 5A). The expression pattern of AgRP followed that of NPY, with elevated AgRP mrna expression levels in pair-fed, but not MTII-treated or PBS-treated mice, after 24 h of treatment, but these differences failed to reach statistical significance. Hypothalamic POMC mrna expression decreased in both MTII-treated and pair-fed lean mice when compared with PBS-treated controls ( % of baseline levels in MTII-treated lean [P 0.05] and % in pair-fed lean mice [P 0.01 vs. the PBS-treated group]). There was a similar POMC mrna expression response to MTII treatment in DIO mice, with a more significant decrease in pair-fed mice ( % of baseline levels in MTIItreated DIO mice [P 0.05 vs. the PBS-treated group and P 0.08 vs. the pair-fed group] and % in pair-fed DIO mice [P vs. the PBS-treated group]). Similar short-term changes in NPY, AgRP, and POMC mrna expression were also observed in ob/ob mice. Neither MTII nor food deprivation, however, had short-term effects on hypothalamic MC4R mrna expression or orexin mrna expression in lean, DIO, and ob/ob mice. Long-term (8-day) effects of MTII or MTII plus leptin administration on mrna expression of hypothalamic neuropeptides in DIO mice. Prolonged MTII treatment failed to prevent food deprivation induced increases in hypothalamic NPY expression. Both pair-fed and MTIItreated DIO mice exhibited a significant increase in hypothalamic NPY mrna expression after 8 days when compared with PBS-treated controls (Fig. 5B). Similarly, mrna expression of AgRP increased by % in pair-fed mice (P 0.05) and % in MTII-treated DIO mice, but this compensatory increase was prevented by a combination treatment of MTII plus leptin ( % in MTII plus leptin treated DIO mice). Hypothalamic POMC mrna expression was similarly decreased in both MTII-treated and pair-fed mice ( % of baseline levels in MTII-treated DIO mice and % in pair-fed DIO mice). Replacement doses of leptin in conjunction with MTII treatment failed to alter the effects observed after MTII alone ( % of baseline levels). MCH mrna expression was significantly decreased after prolonged MTII plus leptin treatment, but failed to change after prolonged MTII treatment or pair-feeding alone ( % of baseline levels in MTII plus leptin-treated mice [P 0.05] vs % in MTII-treated and % in pair-fed mice). Hypothalamic mrna expression of MC4R was not altered after prolonged administration of MTII or MTII plus leptin (data not shown), implying that previously observed decreases in MC4R protein (19) is probably due to posttranscriptional regulation. Orexin mrna expression was not altered after prolonged food deprivation, MTII, or MTII plus leptin administration (data not shown). Effects of MTII on serum adiponectin concentrations, adiponectin mrna expression in WAT, and AdipoR1 and AdipoR2 mrna expression in liver of lean C57BL/6J and DIO mice. Short-term studies (24 h). Because the molecular pathways mediating adiponectin s ability to improve insulin secretion and sensitivity remain largely unknown, we investigated the patterns of adiponectin secretion and mrna expression in WAT and the regulation of AdipoR1 and AdipoR2 in the liver of lean C57BL/6J and DIO mice. Although there was a trend toward elevated circulating adiponectin levels in both lean and obese mice after 24 h of MTII treatment, increased variability prevented these data from reaching statistical significance (data not shown). Similarly, after 24 h of MTII treatment, there were no significant differences in adiponectin mrna expression in the WAT of lean C57BL/6J and DIO mice when compared with respective PBS-treated controls. As previously described in DIO rats (38), however, DIO mice exhibited a significant decrease in adiponectin mrna expression when compared with the lean PBS-treated group ( % of baseline levels in PBS-treated DIO mice and % in pair-fed DIO mice, P for both groups vs. lean PBS-treated mice). We found significant changes in liver AdipoR1 and AdipoR2 mrna expression after food deprivation but not MTII treatment. Specifically, in lean C57BL/6J mice, there were no significant differences in AdipoR1 mrna expression after 24 h of MTII treatment (Fig. 6A), but mice pair-fed to the MTII-treated group exhibited a significant 86 DIABETES, VOL. 53, JANUARY 2004
6 S. BLÜHER AND ASSOCIATES FIG. 6. Liver AdipoR1 mrna expression as the percent change from the lean PBS-treated group (means SE). *P < 0.05, **P < 0.01, ****P < vs. the lean PBS-treated group; #P < 0.05, ##P < 0.01, ###P < vs. the respective PBS-treated group < P < 0.15, P < vs. the respective pair-fed group. increase of % from baseline levels in AdipoR1 mrna expression (P 0.05 vs. the PBS-treated group; Fig. 6A). However, both MTII-treated and pair-fed lean C57BL/6J mice exhibited a significant decrease in AdipoR2 mrna expression after 24 h of treatment or pair-feeding ( % of baseline levels in MTII-treated mice and % in pair-fed mice, P vs. the PBS-treated group; Fig. 7A). DIO mice exhibited significantly increased liver AdipoR1 mrna expression and decreased liver AdipoR2 mrna expression in all three groups (PBS-treated, MTIItreated, and pair-fed mice) when compared with the respective lean PBS-treated mice (Fig. 6A and Fig. 7A), but it remains to be clarified by future studies whether this difference is due to a high-fat diet per se or the more pronounced weight loss of DIO mice seen in this study. We observed no significant differences in both AdipoR1 and AdipoR2 mrna expression in liver after 24 h of MTII treatment, despite a significant increase in liver AdipoR1 RNA expression and decrease in liver AdipoR2 mrna expression in mice pair-fed to the MTII-treated group (Fig. 6A and 7A). Long-term studies. Serum adiponectin did not change in DIO mice after 8 days of MTII administration, MTII plus leptin administration, or pair-feeding (data not shown). Moreover, there were no significant changes in AdipoR1 or AdipoR2 mrna expression after 8 days of MTII treatment (Fig. 6B and 7B). However, DIO mice pair-fed for 8 days to the MTII-treated group, as well as DIO mice administered a combination of MTII plus leptin for 8 days, exhibited a significant increase in liver AdipoR1 mrna expression and a decrease in liver AdipoR2 mrna expression compared with the PBS-treated group (Fig. 6B and 7B). DISCUSSION Peripheral and central MTII treatment decreases body weight by suppressing food intake and increasing energy expenditure (14,21). However, it remains unknown 1) whether MTII is effective in leptin-resistant DIO-, UCP1- DTA, and leptin-sensitive ob/ob obese mice, 2) whether leptin-resistant DIO mice are more sensitive to MTII, and 3) what the mechanisms are that underlie the development DIABETES, VOL. 53, JANUARY
7 MTII: TACHYPHYLAXIS IN OBESE AND LEAN MICE FIG. 7. Liver AdipoR2 mrna expression as the percent change from the lean PBS-treated group (means SE). ****P < vs. the lean PBS-treated group; ####P < vs. the respective PBS-treated group; 0.10 < P < 0.15, P < vs. the respective pair-fed group. of tachyphylaxis and increased insulin sensitivity after MTII treatment. MTII decreases food intake and body weight in both leptin-sensitive and leptin-resistant mice. We first evaluated DIO, a model of acquired leptin and insulin resistance (22) that results in central and peripheral changes in hormonal and neuropeptide levels and/or their signaling pathways (23), and UCP1-DTA mice, which have significantly decreased brown fat ( 20% of control animals) and thus deficient adaptive thermogenesis, leading to an obese phenotype (16,24). UCP1-DTA mice are resistant to the effects of endogenous and exogenously administered leptin on body weight, food intake, and glucose and insulin levels (24,25). We found that food intake, body weight, and insulin levels in both DIO and UCP1-DTA mice decrease after MTII administration, suggesting that this agent acts downstream of the putative point of leptin resistance. Further studies are necessary to assess the relative contribution of increased thermogenesis, lipolysis, and anorexia in the weight-reducing effect of the melanocortin system in these mice. The 24 h of MTII administration also resulted in suppression of cumulative food intake, decreases in body weight, and decreases in circulating insulin levels (59.5%) in leptin-sensitive ob/ob mice (26). Our data are consistent with previous studies demonstrating that a single intraperitoneal dose of MTII to ob/ob mice induces anorexia, shows similar kinetics with a single intracerebroventricular dose to those mice, inhibits feeding potently for the first 4 h (5), and decreases circulating insulin levels by 58% (5). The effects of MTII are more pronounced in DIO mice than in lean mice. MTII administration for 24 h resulted in similar weight loss in lean and DIO mice, but cumulative caloric intake was significantly lower in MTII-treated DIO versus lean mice, suggesting that DIO mice are more sensitive to the hypophagic effects of MTII in the short term. This would be expected to potentially result in more pronounced weight loss after more prolonged administration. Indeed, 4 days of MTII treatment resulted in a more pronounced weight loss and a decrease in caloric intake in DIO mice. Previous studies have shown that food intake is significantly more decreased after a single central MTII injection (27) or peripheral administration for 3 days in obese Zucker (fa/fa) rats with impaired leptin signaling due to defective leptin receptors than in lean controls (28). In addition, DIO Sprague-Dawley rats have significantly 88 DIABETES, VOL. 53, JANUARY 2004
8 S. BLÜHER AND ASSOCIATES enhanced nocturnal inhibitory feeding responses to a single intracerebroventricular injection of -melanocyte stimulating hormone when compared with lean controls in both the short and long term (29). However, we show for the first time that melanocortins are more potent in DIO mice when compared with lean controls by inducing a more pronounced decrease in food intake and body weight in DIO mice. We therefore suggest that leptin-resistant obese rodents may have a reduced endogenous melanocortin tone, probably due to a lack of leptin action, which results in increased MTII sensitivity. Hypothalamic NPY levels are suppressed after MTIIinduced food deprivation but rise after prolonged administration. MTII acutely decreases appetite and body weight in rodents, but tachyphylaxis to chronic central or peripheral MTII administration has been observed in mice (14) and rats (30,31). We found that although MTII may prevent food deprivation induced increases in hypothalamic NPY and possibly AgRP mrna expression in the short term, both NPY and AgRP mrna increase toward levels seen in the pair-fed animals after 8 days of MTII administration, suggesting that this increase in hypothalamic NPY and AgRP mrna levels might mediate, in part, the tachyphylactic effects of prolonged MTII treatment. It has recently been shown that tachyphylaxis is due to downregulation of the MC4R protein (19). Because mrna expression of MC4R is not altered after short-term or prolonged administration of MTII, this regulation may occur at the translational level, but future studies are needed to investigate this topic in detail as well as to examine expression of hypothalamic neuropeptides or synaptic activity in specific areas of the hypothalamus (29). Our data are consistent with the physiological outcomes of this study, including the fact that MTII-treated mice don t regain weight 4 days after treatment, nor do they increase their food intake, but just fail to lose additional weight. A direct effect of melanocortins on the NPYnergic system is also consistent with the presence of MC3 receptors on NPY neurons (32). Because NPY neurons have been shown to have a regulatory effect on POMC neurons (33), it is reasonable to speculate that a prolonged effect of leptin or melanocortins on NPY may result in compensatory changes in the endogenous melanocortin system. Similar to melanocortin agonists, NPY antagonists have been shown to exert stronger effects on reducing food intake in obese leptin-resistant Zucker (fa/fa) rats than in lean controls (34). However, NPY-deficient mice (NPY / ) exhibit a normal response to centrally administered MTII (35), suggesting that additional molecules other than NPY may mediate the effects of MTII. We found that changes in both NPY and AgRP may mediate the short-term effects of MTII (36). Because both NPY and AgRP mrna levels rise after chronic administration toward levels seen in the pair-fed mice, explaining in part why the effect of MTII wanes after prolonged administration, it is possible that a combined treatment of MTII with NPY and AgRP antagonists might provide a valuable drug combination for obesity. In addition, a combination treatment of MTII and leptin decreases body weight more significantly than MTII treatment or pair-feeding alone because of either the direct lipolytic effects of leptin or altered energy homeostasis. A combination treatment of MTII plus leptin for 8 days, but not MTII administration alone, prevents changes in MCH, NPY, and AgRP mrna expression, suggesting that leptin may in part act to prevent the development of tachyphylaxis by altering hypothalamic neuropeptide levels. We thus conclude that decreasing leptin levels after MTIIinduced weight loss might play a minor role in the development of tachyphylaxis, and a combination treatment of leptin and MTII may prove more effective in causing lipolysis and resulting in an additional decrement of body weight. Altered insulin sensitivity and insulin levels after food deprivation or MTII administration may be in part mediated by alterations in adiponectin receptor levels. MTII acts as a potent insulin-sensitizing agent in mice (14,37), but the mechanisms underlying this effect, although poorly characterized, seem not to include increases in adiponectin expression and secretion (38), for there were no significant changes in adiponectin levels in lean or obese C57BL/6J mice after MTII treatment. After food deprivation and MTII administration, we observed significant changes in the liver mrna expression of AdipoR1, a high-affinity receptor for globular adiponectin, and AdipoR2, an intermediate-affinity receptor for both globular and full-length adiponectin, both of which appear to mediate adiponectin-stimulated fatty acid oxidation and possibly hepatic glucose uptake (20). Further, we demonstrate that, in contrast to the tachyphylaxis observed in terms of hypothalamic neuropeptide responses to MTII, no peripheral tachyphylaxis is seen with respect to the effects of MTII on adiponectin receptor expression in the liver. Future studies investigating the physiological regulation of adiponectin and its receptors, as well as identification of the signaling pathways downstream of adiponectin receptors in lean and obese mice, may prove to be of significant importance in determining the mechanisms underlying insulin resistance. In summary, our results suggest that 1) MTII is an effective treatment for obesity and related metabolic defects in leptin-resistant and leptin-sensitive mouse models of obesity; 2) DIO mice appear to be more sensitive to MTII treatment because the effects of MTII on food intake and body weight are more pronounced in DIO than lean mice; 3) the short-term effects of MTII to induce anorexia may, at least in part, be mediated by altered hypothalamic NPY mrna levels; 4) the tachyphylactic effect after prolonged MTII administration may, at least in part, be caused by a compensatory increase of NPY mrna concentrations and possibly AgRP mrna concentrations; 5) alterations in orexin, MCH, and MC4R mrna expression do not appear to play a role of comparable importance, whereas decreasing leptin levels appear to play a minor role in the development of tachyphylaxis; and 6) alterations in adiponectin receptor mrna expression after food deprivation, as well as short- and long-term MTII administration, may play a role in altering insulin sensitivity and needs to be studied further. Finally, our data provide further evidence that melanocortin receptor agonists offer a potential therapeutic approach to syndromes of obesity accompanied by leptin resistance and metabolic abnormalities (37) and raise the possibility that a combination treatment with DIABETES, VOL. 53, JANUARY
9 MTII: TACHYPHYLAXIS IN OBESE AND LEAN MICE leptin or NPY and AgRP antagonists might provide an even more effective treatment option for obesity. REFERENCES 1. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ: Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: , Yaswen L, Diehl N, Brennan MB, Hochgeschwender U: Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5: , Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: , Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26:97 102, Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: , Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Bum P, Palmiter RD: Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21: , Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, Steiner RA: Differential role of melanocortins in mediating leptin s central effects on feeding and reproduction. Am J Physiol Regul Integr Comp Physiol 278:R50 R59, Koegler FH, Grove KL, Schiffmacher A, Smith MS, Cameron JL: Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology 142: , Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM, Mellin TN: Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J Appl Physiol 89: , Forbes S, Bui S, Robinson BR, Hochgeschwender U, Brennan MB: Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci USA98: , Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RA, Baskin DG, Schwartz MW, van Dijk G: Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci 21: , Satoh N, Ogawa Y, Katsuura G, Numuta Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249: , Kask A, Schioth HB, Harro J, Wikberg JE, Rago L: Longitudinal administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. Neuroreport 10: , Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS: Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51: , Mantzoros CS, Qu D, Frederich RC, Susulic VS, Lowell BB, Maratos-Flier E, Flier JS: Activation of (3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 45: , Lowell BB, Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: , Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS: Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279:E838 E845, Ziotopoulou M, Erani DM, Hileman SM, Bjorbaek C, Mantzoros CS: Unlike leptin, ciliary neurotrophic factor does not reverse the starvation induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. Diabetes 49: , Shinyama H, Masuzaki H, Fang H, Flier JS: Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144: , Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: , Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir LF, Schiöth HB: Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport 12: , Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1: , El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: , Hamann A, Flier JS, Lowell BB: Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21 29, Mantzoros CS, Frederich RC, Qu D, Lowell BB, Maratos-Flier E, Flier JS: Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptidey and circulating corticosterone concentrations. Diabetes 47: , Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: , Hwa JJ, Ghibaudi L, Gao J, Parker EM: Central melanocortin system modulated energy intake and expenditure of obese and lean Zucker rats. Am J Physiol Regul Integr Comp Physiol 281:R444 R451, Cettour-Rose P, Rohner-Jeanrenaud F: The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143: , Hansen MJ, Ball MJ, Morris MJ: Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892: , McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW: Effect of intracerebroventricular alpha-mhs on food intake, adiposity, c-fos induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 27:R695 R703, Jonsson L, Skarphedinsson JO, Skuladottir GV, Watanobe H, Schioth HB: Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J Endocrinol 173: , Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, Barsh GS, Watson SJ: Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in the brain. J Neurosci 19:RC26:1 7, Garcia de Yebenes E, Li S, Fournier A, St-Pierre S, Pelletier G: Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res 674: , Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M, Fukuroda T: A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am J Physiol 274:R1500 R1504, Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD: Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res 848:66 77, Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR: Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49: , Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD: The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141: , Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R: Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10: , DIABETES, VOL. 53, JANUARY 2004
Chronic Stimulation of Leptin on Food Intake and Body Weight after Microinjection into the Ventromedial Hypothalamus of Conscious Rats
TAJ December 2006; Volume 19 Number 2 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Original Article Chronic Stimulation of Leptin on Food Intake and Body Weight after Micro into the
More informationFigure 1: The leptin/melanocortin pathway Neuronal populations propagate the signaling of various molecules (leptin, insulin, ghrelin) to control
Leptin Deficiency Introduction The leptin/melanocortin pathway plays a key role in the hypothalamic control of food intake. It is activated following the systemic release of the adipokine leptin (LEP)
More informationLean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness
Diabetologia (27) 5:149 1499 DOI 1.7/s125-7-685-1 ARTICLE Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness
More informationAdaptive increases of food intake induced by
Attenuation of Diabetic Hyperphagia in Neuropeptide Y Deficient Mice Dana K. Sindelar, 1 Paul Mystkowski, 1 Donald J. Marsh, 2 Richard D. Palmiter, 2 and Michael W. Schwartz 1 The combined effects of increased
More informationAlthough obesity is a major cause of human essential
Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation? Alexandre A. da Silva, Jay J. Kuo, Lakshmi S. Tallam, Jiankang Liu, John E.
More informationThe central melanocortin system affects the hypothalamopituitary thyroid axis and may mediate the effect of leptin
The central melanocortin system affects the hypothalamopituitary thyroid axis and may mediate the effect of leptin M.S. Kim, C.J. Small, S.A Stanley, D.G.A. Morgan, L.J. Seal, W.M. Kong, C.M.B. Edwards,
More informationBIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationThe Effects of the Melanocortin Agonist (MT-II) on Subcutaneous and Visceral Adipose Tissue in Rodents
0022-3565/07/3223-1153 1161$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 322, No. 3 Copyright 2007 by The American Society for Pharmacology and Experimental Therapeutics 123091/3245087
More informationAnalyses of mutations at the agouti (A) locus along with
A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors Linda Ste. Marie*, Grant I. Miura*, Donald J. Marsh*, Keith Yagaloff, and Richard D. Palmiter* *Howard Hughes Medical Institute
More informationRole of the CNS Melanocortin System in the Response to Overfeeding
The Journal of Neuroscience, March 15, 1999, 19(6):2362 2367 Role of the CNS Melanocortin System in the Response to Overfeeding Mary M. Hagan, 1 Paul A. Rushing, 1 Michael W. Schwartz, 2 Keith A. Yagaloff,
More informationYiying Zhang, PhD Research Scientist. Research Summary:
Yiying Zhang, PhD Research Scientist Research Summary: Address: Naomi Berrie Diabetes Center at Columbia University Medical Center Russ Berrie Medical Science Pavilion 1150 St. Nicholas Avenue New York,
More informationNeurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction. Laura Gunter
Neurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction Laura Gunter The Brain as the Regulatory Center for Appetite The brain is the integration center
More informationThe role of leptin in leptin resistance and obesity
Physiology & Behavior 88 (2006) 249 256 The role of leptin in leptin resistance and obesity Yi Zhang a,b, Philip J. Scarpace b, a Research Service, Department of Veterans Affairs Medical Center, Gainesville,
More informationPeripubertal, leptin-deficient ob/ob female mice were used in an investigation of
ESSICK-BROOKSHIRE, ELIZABETH ANN, M.S. The Effects of Peripherally Administered 17-β Estradiol and BIBP3226, a NPY Y1 Receptor Antagonist, on Food Intake, Body Mass, Reproductive Development and Behavior
More informationLow ambient temperature lowers cholecystokinin and leptin plasma concentrations in adult men
ISPUB.COM The Internet Journal of Gastroenterology Volume 7 Number 2 Low ambient temperature lowers cholecystokinin and leptin plasma concentrations in adult men M Pizon, P Tomasic, K Sztefko, Z Szafran
More informationObesity in aging: Hormonal contribution
Obesity in aging: Hormonal contribution Hormonal issues in obesity and aging Hormonal role in regulation of energy balance Genetic component in hormonal regulation Life style contribution to hormonal changes
More informationMahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti
Proc. Natl. Acad. Sci. USA Vol. 95, pp. 12707 12712, October 1998 Physiology Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti DANIELA M. DINULESCU*,
More informationInsulin-Leptin Interactions
Insulin-Leptin Interactions Ahmed S., Al-Azzam N., Cao B. Karshaleva B., Sriram S., Vu K. If you understand a system, you can predict it. Agenda - Energy homeostasis Overview of leptin and insulin Signaling
More informationGenetic disruption of either mouse or human
ORIGINAL ARTICLE In Vivo Evidence for Inverse Agonism of Agouti-Related Peptide in the Central Nervous System of Proopiomelanocortin-Deficient Mice Virginie Tolle 1,2 and Malcolm J. Low 1,2,3 OBJECTIVE
More informationInternal Regulation II Energy
Internal Regulation II Energy Reading: BCP Chapter 16 lookfordiagnosis.com Homeostasis Biologically, what is necessary for life is a coordinated set of chemical reactions. These reactions take place in
More informationCNS Control of Food Intake. Adena Zadourian & Andrea Shelton
CNS Control of Food Intake Adena Zadourian & Andrea Shelton Controlling Food Intake Energy Homeostasis (Change in body adiposity + compensatory changes in food intake) Background Information/Review Insulin
More informationMethod of leptin dosing, strain, and group housing influence leptin sensitivity in high-fat-fed weanling mice
Am J Physiol Regul Integr Comp Physiol 284: R87 R100, 2003; 10.1152/ajpregu.00431.2002. Method of leptin dosing, strain, and group housing influence leptin sensitivity in high-fat-fed weanling mice HEATHER
More informationLeptin Intro/Signaling. ATeamP: Angelo, Anthony, Charlie, Gabby, Joseph
Leptin Intro/Signaling ATeamP: Angelo, Anthony, Charlie, Gabby, Joseph Overview Intro to Leptin Definition & Sources Physiology Bound vs. Free Receptors Signaling JAK/STAT MAPK PI3K ACC Experimental findings
More informationCopyright 2017 The Guilford Press
This is a chapter excerpt from Guilford Publications. Eating Disorders and Obesity: A Comprehensive Handbook, Third Edition. Edited by Kelly D. Brownell and B. Timothy Walsh. Copyright 2017. Purchase this
More informationRecent years have seen remarkable progress in. Is the Energy Homeostasis System Inherently Biased Toward Weight Gain?
Is the Energy Homeostasis System Inherently Biased Toward Weight Gain? Michael W. Schwartz, 1 Stephen C. Woods, 2 Randy J. Seeley, 2 Gregory S. Barsh, 3 Denis G. Baskin, 1,4 and Rudolph L. Leibel 5 We
More informationA Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences
The Journal of Neuroscience, May 1, 2000, 20(9):3442 3448 A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences Stephen C. Benoit,
More informationThe melanocortin system in the mammalian forebrain
Leptin Increases Hypothalamic Pro-opiomelanocortin mrna Expression in the Rostral Arcuate Nucleus Michael W. Schwartz, Randy J. Seeley, Stephen C. Woods, David S. Weigle, L. Arthur Campfield, Paul Burn,
More informationManagement of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.
Medical Management of Obesity Ben O Donnell, MD 1 Objectives Background Impact and scope of Obesity Control of Energy Homeostasis Methods of treatment Medications 2 O'Donnell 1 Impact of Obesity According
More informationLEPTIN IS A CRUCIAL factor in the regulation of energy
0013-7227/03/$15.00/0 Endocrinology 144(6):2741 2748 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/en.2003-0031 Neuronal Histamine Regulates Food Intake, Adiposity, and Uncoupling
More informationMotivation 1 of 6. during the prandial state when the blood is filled
Motivation 1 of 6 I. INTRODUCTION A. Motivation: a condition (usually internal) that initiates, activates, or maintains goal-directed behavior. B. Archery analogy 1. undrawn bow has no potential energy
More informationBi156 lecture 2, 1/6/12. Eating and weight regulation
Bi156 lecture 2, 1/6/12 Eating and weight regulation Introduction: weight regulation in an affluent society In our society much effort and money is expended on regulation of weight. Failure to maintain
More informationMeccanismi fisiopatologici e trattamento dei disturbi metabolici in soggetti affetti da disturbo mentale grave
Meccanismi fisiopatologici e trattamento dei disturbi metabolici in soggetti affetti da disturbo mentale grave Francesco Bartoli, MD, PhD Università degli Studi di Milano Bicocca Ospedale San Gerardo di
More informationEffects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice
Effects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice Rasha Mosa (MBCHC, M.D, PhD candidate) School of Biomedical Sciences University of Queensland
More informationObesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation
The International Journal of Biochemistry & Cell Biology 37 (2005) 2254 2259 Medicine in focus Obesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation Woo Je Lee, Eun Hee
More informationIngestive Behaviors 33. Introduction. Page 1. control and story lines. (a review of general endocrinology) Integration (or the basic reflex arc model)
Ingestive Behaviors 33 (a review of general endocrinology) A neuroendocrine system: components, a reflex arc, the endocrine system, the AN, endocrine / nervous systems as afferents and efferents, the theoretical
More informationChapter 12. Ingestive Behavior
Chapter 12 Ingestive Behavior Drinking a. fluid compartments b. osmometric thirst c. volumetric thirst Eating a. energy sources b. starting a meal c. stopping a meal d. eating disordersd Drinking a. fluid
More informationSupplemental data Supplemental Figure Legends Supplemental Figure 1. Supplemental Figure 2.
Supplemental data Supplemental Figure Legends Supplemental Figure 1. Analysis of deletion of AMPK!2 in POMC and AgRP neurons in control and POMC!2KO and AgRP!2KO mice. (A) mmunofluorescence analysis for
More informationObesity is a major risk factor for many diseases, Adrenalectomy Alters the Sensitivity of the Central Nervous System Melanocortin System
Adrenalectomy Alters the Sensitivity of the Central Nervous System Melanocortin System Deborah L. Drazen, 1 Matthew D. Wortman, 1 Michael W. Schwartz, 2 Deborah J. Clegg, 1 Gertjan van Dijk, 3 Stephen
More informationIs ghrelin a signal for the development of metabolic systems?
Commentaries Is ghrelin a signal for the development of metabolic systems? Kevin L. Grove and Michael A. Cowley Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science
More informationMice lacking the syndecan-3 gene are resistant to diet-induced obesity
Research article Mice lacking the syndecan-3 gene are resistant to diet-induced obesity April D. Strader, 1 Ofer Reizes, 2 Stephen C. Woods, 1 Stephen C. Benoit, 1 and Randy J. Seeley 1 1 Department of
More informationGPR120 *** * * Liver BAT iwat ewat mwat Ileum Colon. UCP1 mrna ***
a GPR120 GPR120 mrna/ppia mrna Arbitrary Units 150 100 50 Liver BAT iwat ewat mwat Ileum Colon b UCP1 mrna Fold induction 20 15 10 5 - camp camp SB202190 - - - H89 - - - - - GW7647 Supplementary Figure
More informationAppeal decision. Appeal No USA HILL'S PET NUTRITION, INC. Osaka, Japan
Appeal decision Appeal No. 2015-17056 USA Appellant HILL'S PET NUTRITION, INC. Osaka, Japan Patent Attorney MURAI, Koji The case of appeal against the examiner's decision of refusal of Japanese Patent
More informationChapter 1. General introduction. Part of this chapter is adapted from Adan et.al., Br.J.Pharmacol. 2006;149:815
Chapter 1 General introduction Part of this chapter is adapted from Adan et.al., Br.J.Pharmacol. 2006;149:815 Chapter 1 B. Tiesjema, 2007 GENERAL INTRODUCTION NEURAL CIRCUITS INVOLVED IN ENERGY BALANCE
More informationCentral Nervous System Regulation of Food Intake
Central Nervous System Regulation of Food Intake Michael W. Schwartz Introduction Some 50 years ago, Gordon Kennedy introduced the hypothesis that body fat stores are subject to homeostatic regulation
More informationPAPER The NPY=AgRP neuron and energy homeostasis
(2001) 25, Suppl 5, S56 S62 ß 2001 Nature Publishing Group All rights reserved 0307 0565/01 $15.00 www.nature.com/ijo PAPER and energy homeostasis GJ Morton 1 and MW Schwartz 1 * 1 Department of Medicine,
More informationGlucocorticoids Exacerbate Obesity and Insulin Resistance in Neuron-Specific Proopiomelanocortin-Deficient Mice
Digital Commons @ George Fox University Faculty Publications - Department of Biology and Chemistry Department of Biology and Chemistry 2-2006 Glucocorticoids Exacerbate Obesity and Insulin Resistance in
More information1 Neuroregulation of Appetite
Chapter 1 / Neuroregulation of Appetite 3 1 Neuroregulation of Appetite Ofer Reizes, PhD, Stephen C. Benoit, PhD, and Deborah J. Clegg, PhD CONTENTS INTRODUCTION THE DUAL-CENTERS HYPOTHESIS CONTROL OF
More informationDefective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance
Cell Metabolism, Volume 11 Supplemental Information Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, and Gökhan S. Hotamisligil
More informationThe hypothalamic melanocortin system is a regulator
Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals Caroline J. Small, Min S. Kim, Sarah A. Stanley, John R.D. Mitchell, Kevin Murphy, David G.A. Morgan,
More informationCentral injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents Jarrad M Scarlett 1,,1, Jennifer M Rojas 1,1, Miles E Matsen 1, Karl J Kaiyala 3, Darko
More informationInsulin and Leptin as Adiposity Signals
Insulin and Leptin as Adiposity Signals STEPHEN C. BENOIT, DEBORAH J. CLEGG, RANDY J. SEELEY, AND STEPHEN C. WOODS Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267
More informationMary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Is obesity a brain disorder? What is the evidence to support obesity is a brain disorder? Environmental, biological, and behavioral issues Over
More informationEffect of Immune Challenge on Different Genotypes: How Sick Do They Get?
Introduction Effect of Immune Challenge on Different Genotypes: How Sick Do They Get? M.T. Leininger, C.P. Portocarrero, C.A. Bidwell, M.E. Spurlock, J.N. Nielsen, and K.L. Houseknecht Department of Animal
More informationLESSON 3.3 WORKBOOK. How do we decide when and how much to eat?
Appetite The psychological desire to eat, driven by feelings of pleasure from the brain. Hunger The biological or physiological need to eat, caused by a release of hormones from the digestive tract. LESSON
More informationGut hormones KHATTAB
Gut hormones PROF:ABD ALHAFIZ HASSAN KHATTAB Gut as an endocrine gland The talk will cover the following : Historical background. Why this subject is chosen. Gastro-intestinal hormones and their function.
More informationIngestive Behaviors 21. Introduction. Page 1. control and story lines. (a review of general endocrinology) Integration (or the basic reflex arc model)
Ingestive Behaviors 21 (a review of general endocrinology) A neuroendocrine system: components, a reflex arc, the endocrine system, the AN, endocrine / nervous systems as afferents and efferents, the theoretical
More informationHomeostasis and Mechanisms of Weight Regulation
Homeostasis and Mechanisms of Weight Regulation Purpose In this activity students will investigate how negative feedback mechanisms function to maintain homeostatic balance using a recently discovered
More informationLeptin Action in the Dorsomedial Hypothalamus Increases Sympathetic Tone to Brown Adipose Tissue in Spite of Systemic Leptin Resistance
The Journal of Neuroscience, August 24, 2011 31(34):12189 12197 12189 Neurobiology of Disease Leptin Action in the Dorsomedial Hypothalamus Increases Sympathetic Tone to Brown Adipose Tissue in Spite of
More informationGhrelin mediates stressinduced. behavior in mice. Chuang et al 2011 L3: Love, Lust, Labor
Ghrelin mediates stressinduced food-reward behavior in mice Chuang et al 2011 L3: Love, Lust, Labor Agenda Introduction What is Ghrelin? Previous Models New model Methods Results Discussion Conclusion
More informationA novel role for vitamin D: modulation of expression and function of the local renin angiotensin system in mouse pancreatic islets
Diabetologia () 5:77 DOI.7/s5--- SHORT COMMUNICATION A novel role for vitamin D: modulation of expression and function of the local renin angiotensin system in mouse pancreatic islets Q. Cheng & Y. C.
More informationa b c Physical appearance of mice Lean mass Adipocyte size d e f
LFD HFD LFD HFD Area under curve (GTT) HFD-VSL#3 LFD HFD Area under curve (ITT) HFD-VSL#3 Liver TG content (% l) HFD-VSL#3 LFD HFD HFD-VSL#3 LFD HFD HFD-VSL#3 LFD HFD HFD + VSL#3 Lean mass (gm) Mean adipocyte
More informationRegulation of adipose tissue remodeling by peripheral serotonin
Regulation of adipose tissue remodeling by peripheral serotonin Sangkyu Park Catholic Kwandong University College of Medicine Department of Biochemistry Serotonin (5-HT) is a signaling molecule Hemostasis
More informationThe effect of melanocortin (Mc3 and Mc4) antagonists on serotonin-induced food and water intake of broiler cockerels
pissn 1229-845X, eissn 1976-555X J. Vet. Sci. (2012), 13(3), 229-234 http://dx.doi.org/10.4142/jvs.2012.13.3.229 Received: 3 Jun. 2011, Revised: 27 Sep. 2011, Accepted: 19 Apr. 2012 Original Article JOURNAL
More informationChapter 24 Cholesterol, Energy Balance and Body Temperature. 10/28/13 MDufilho
Chapter 24 Cholesterol, Energy Balance and Body Temperature 10/28/13 MDufilho 1 Metabolic Role of the Liver Hepatocytes ~500 metabolic functions Process nearly every class of nutrient Play major role in
More informationAMPK. Tomáš Kučera.
AMPK (AMP- ACTIVATED PROTEIN KINASE ) Tomáš Kučera tomas.kucera@lfmotol.cuni.cz Department of Medical Chemistry and Clinical Biochemistry 2nd Faculty of Medicine, Charles University in Prague and Motol
More informationAn important function of the central nervous
Perspectives in Diabetes Insulin Signaling in the Central Nervous System A Critical Role in Metabolic Homeostasis and Disease From C. elegans to Humans Daniel Porte, Jr., 1,2,3 Denis G. Baskin, 3 and Michael
More informationTHE PERENNIAL STRUGGLE TO LOSE WEIGHT AND MAINTAIN: WHY IS IT SO DIFFICULT?
THE PERENNIAL STRUGGLE TO LOSE WEIGHT AND MAINTAIN: WHY IS IT SO DIFFICULT? Robert Ferraro, MD Medical Director Southwest Endocrinology Associates, PA Diabetes and Weight Management Center OBESITY The
More informationWhy Obesity Is A Chronic Disease
Why Obesity Is A Chronic Disease Arya M Sharma, MD, FRCP(C) Professor of Medicine Chair in Obesity Research & Management University of Alberta Edmonton, AB, Canada www.drsharma.ca Global Obesity Map 2014
More informationAdipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University
Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,
More informationSleeve Gastrectomy Induces Loss of Weight and Fat Mass in Obese Rats, but Does Not Affect Leptin Sensitivity
GASTROENTEROLOGY 2010;138:2426 2436 Sleeve Gastrectomy Induces Loss of Weight and Fat Mass in Obese Rats, but Does Not Affect Leptin Sensitivity MARGARET A. STEFATER,* DIEGO PÉREZ TILVE,* ADAM P. CHAMBERS,*
More informationrapid communication Leptin disinhibits nonshivering thermogenesis in infants after maternal separation
rapid communication Leptin disinhibits nonshivering thermogenesis in infants after maternal separation MARK S. BLUMBERG, KARA DEAVER, AND ROBERT F. KIRBY Department of Psychology, The University of Iowa,
More informationEmpower Preventive Medicine. Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL
Empower Preventive Medicine Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL 32217 904-367-4005 Drtim@emprevmed.com Obesity Medicine Old paradigm: Obesity was a matter of willpower,
More informationCharacterization of a novel genetically obese mouse model demonstrating early onset hyperphagia and hyperleptinemia
Am J Physiol Endocrinol Metab 305: E451 E463, 2013. First published June 4, 2013; doi:10.1152/ajpendo.00540.2012. Characterization of a novel genetically obese mouse model demonstrating early onset hyperphagia
More informationEFFECTS OF RECOMBINANT ADENO-ASSOCIATED VIRUS ENCODING LEPTIN ON BODY WEIGHT REGULATION AND ENERGY HOMEOSTASIS
EFFECTS OF RECOMBINANT ADENO-ASSOCIATED VIRUS ENCODING LEPTIN ON BODY WEIGHT REGULATION AND ENERGY HOMEOSTASIS By HARVEEN DHILLON A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA
More informationCentral nervous system control of food intake
insight review article Central nervous system control of food intake Michael W. Schwartz*, Stephen C. Woods, Daniel Porte Jr*, Randy J. Seeley & Denis G. Baskin* Departments of Medicine* and Biological
More informationEnergy Balance. Applied Human Metabolism VII. Energy Out. Factors that effect BMR/RMR 17/03/2016
Energy Balance Applied Human Metabolism VII Weight Regulation The balance of energy taken in or leaving the body determines body mass Energy In = Energy Out Weight Maintenance Energy In < Energy Out Weight
More informationInsights from Rare Obesity Disorders
Insights from Rare Obesity Disorders Ashley Shoemaker, MD, MSCI Ian M. Burr Division of Pediatric Endocrinology and Diabetes Disclosures Research funding: Zafgen, AstraZeneca, Rhythm Member, Zafgen Hypothalamic
More informationAMPK. Tomáš Kuc era. Ústav lékar ské chemie a klinické biochemie 2. lékar ská fakulta, Univerzita Karlova v Praze
AMPK (AMP- ACTIVATED PROTEIN KINASE ) Tomáš Kuc era Ústav lékar ské chemie a klinické biochemie 2. lékar ská fakulta, Univerzita Karlova v Praze 2013 AMPK AMP-ACTIVATED PROTEIN KINASE present in all eukaryotic
More informationPostnatal Development of Hypothalamic Leptin Receptors
CHAPTER ELEVEN Postnatal Development of Hypothalamic Leptin Receptors Elizabeth C. Cottrell,*,1 Julian G. Mercer, and Susan E. Ozanne* Contents I. Introduction 202 II. The Leptin System 203 A. Sources
More informationRegulation of leptin by agouti
Physiol Genomics 2: 101 105, 2000. Regulation of leptin by agouti KATE J. CLAYCOMBE, 1 BING ZHONG XUE, 1 RANDALL L. MYNATT, 2 MICHAEL B. ZEMEL, 1 AND NAIMA MOUSTAID-MOUSSA 1 1 Department of Nutrition,
More informationA Tryptophan Hydroxylase Inhibitor Decreases Hepatic FGF21 Expression and Circulating FGF21 in Mice Fed A High-Fat Diet
A Tryptophan Hydroxylase Inhibitor Decreases Hepatic FGF21 Expression Circulating FGF21 in Mice Fed A High-Fat Diet Katsunori Nonogaki, Takao Kaji, Mari Murakami Abstract Background: Fibroblast growth
More informationInjectable GLP 1 therapy: weight loss effects seen in obesity with and without diabetes
Injectable GLP 1 therapy: weight loss effects seen in obesity with and without diabetes Dr Masud Haq Consultant Lead in Diabetes & Endocrinology Maidstone & Tunbridge Wells NHS Trust & The London Preventative
More informationcontrol kda ATGL ATGLi HSL 82 GAPDH * ** *** WT/cTg WT/cTg ATGLi AKO/cTg AKO/cTg ATGLi WT/cTg WT/cTg ATGLi AKO/cTg AKO/cTg ATGLi iwat gwat ibat
body weight (g) tissue weights (mg) ATGL protein expression (relative to GAPDH) HSL protein expression (relative to GAPDH) ### # # kda ATGL 55 HSL 82 GAPDH 37 2.5 2. 1.5 1..5 2. 1.5 1..5.. Supplementary
More informationThe Physiology of Weight Regulation: Implications for Effective Clinical Care
Roundtable on Obesity Solutions The Physiology of Weight Regulation: Implications for Effective Clinical Care Lee M. Kaplan, MD, PhD Obesity, Metabolism & Nutrition Institute Massachusetts General Hospital
More informationMales- Western Diet WT KO Age (wks) Females- Western Diet WT KO Age (wks)
Relative Arv1 mrna Adrenal 33.48 +/- 6.2 Skeletal Muscle 22.4 +/- 4.93 Liver 6.41 +/- 1.48 Heart 5.1 +/- 2.3 Brain 4.98 +/- 2.11 Ovary 4.68 +/- 2.21 Kidney 3.98 +/-.39 Lung 2.15 +/-.6 Inguinal Subcutaneous
More informationThe role of leptin receptor signaling in feeding and neuroendocrine function
Review TRENDS in Endocrinology and Metabolism Vol.14 No.10 December 2003 447 The role of leptin receptor signaling in feeding and neuroendocrine function Sarah H. Bates and Martin G. Myers Jr Research
More informationPERSPECTIVE. The hardship of obesity: a soft-wired hypothalamus. Tamas L Horvath FEEDING REGULATION AND OBESITY
FEEDING REGULATION AND OBESITY PERSPECTIVE The hardship of obesity: a soft-wired hypothalamus Tamas L Horvath Food intake and energy expenditure are determinants of metabolic phenotype and are regulated
More informationUnderstanding obesity by local overexpression of neuropeptides: a viral vector based approach
Understanding obesity by local overexpression of neuropeptides: a viral vector based approach Cover photo: Chris Timmers Cover design: Marije Tiesjema Print: Gildeprint, Enschede ISBN: 978-90-39344675
More informationActivités scientifiques
Prof. Françoise Rohner-Jeanrenaud Activités scientifiques I. A role for adipose tissue de novo lipogenesis in glucose homeostasis during catch-up growth: A Randle cycle favoring fat storage Catch-up growth
More informationLeptin-Insulin Signaling in the Brain. BY TEAM CEPHALIC Aman Hamdard, Kevin Artiga, Megan Imreh, Ronald Baldonado, and Sharri Mo
Leptin-Insulin Signaling in the Brain BY TEAM CEPHALIC Aman Hamdard, Kevin Artiga, Megan Imreh, Ronald Baldonado, and Sharri Mo Agenda Leptin in the Hypothalamus: Pathways and Roles Cross-talk between
More informationHypothalamic NPY, AGRP, and POMC mrna responses to leptin and refeeding in mice
Am J Physiol Regul Integr Comp Physiol 283: R1020 R1026, 2002; 10.1152/ajpregu.00501.2001. Hypothalamic NPY, AGRP, and POMC mrna responses to leptin and refeeding in mice I. SWART, 1 J. W. JAHNG, 2 J.
More informationPHS 398 (Rev. 4/98) (From Page 6) Page 1 Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b.
BIOGRAPHICAL SKETCH Provide the following information for the key personnel in the order listed on Form Page 2. Photocopy this page or follow this format for each person. NAME POSITION TITLE Christos S.
More informationThe physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS
FEBS Letters 582 (2008) 74 80 Minireview The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS Takashi Kadowaki a,b, *, Toshimasa Yamauchi
More informationInhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice
Diabetologia (2006) 49: 1333 1337 DOI 10.1007/s00125-006-0239-y SHORT COMMUNICATION S. J. Y. Wang. S. Birtles. J. de Schoolmeester. J. Swales. G. Moody. D. Hislop. J. O Dowd. D. M. Smith. A. V. Turnbull.
More informationHormones and Neurons
Hormones and Neurons Appetite Regulation and Weight Control The Story of Leptin, Ghrelin, and PYY and the Treatment of Obesity Michael A. Bush, M.D. CA-AACE Annual Meeting Symposium May 5, 2017 1 phat
More informationSupplementary Figure S1. Effect of Glucose on Energy Balance in WT and KHK A/C KO
Supplementary Figure S1. Effect of Glucose on Energy Balance in WT and KHK A/C KO Mice. WT mice and KHK-A/C KO mice were provided drinking water containing 10% glucose or tap water with normal chow ad
More informationSupplemental methods. Total RNA was extracted from the stomach, liver, pancreas, pituitary, and
Supplemental methods Real-time quantitative RT-PCR and Semi-quantitative PCR Total RNA was extracted from the stomach, liver, pancreas, pituitary, and hypothalamus as previously described (). Primers and
More informationRole of leptin in obesity-related hypertension
Exp Physiol 90.5 pp 683 688 683 Experimental Physiology Symposium Report Role of leptin in obesity-related hypertension William G. Haynes General Clinical Research Center, Carver College of Medicine, University
More informationHypothalamic TLR2 triggers sickness behavior via a microglia-neuronal axis
Hypothalamic TLR triggers sickness behavior via a microglia-neuronal axis Sungho Jin, *, Jae Geun Kim,, *, Jeong Woo Park, Marco Koch,, Tamas L. Horvath and Byung Ju Lee Department of Biological Sciences,
More information